NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/16/2023
Back to search
Official data from USPTO
CAMBRIDGE PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CAMBRIDGE PHARMA
ST13
US500000088667774Class
40
Filing
88667774
Registration
7057307
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
07/08/2023
Trademark type
Word
Nice classes
40
Filing date
10/24/2019
Registration date
05/16/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2023
Last transaction
07/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
02/15/2021
First use in commerce
02/15/2021
Drawing code
4
Owner type
99
Owner location
Cambridge, GB
Examiner
DUBRAY, KATHERINE
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cambridge Pharma Limited
Representatives
Michael T. Olsen WINTHROP & WEINSTINE, P.A.
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of pharmaceuticaldiagnostic and medical devices; custom manufacture of plastic injection molding parts
Publications
History of USPTO decisions and trademark events.
42 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/16/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/12/2023
ALIE
ASSIGNED TO LIE
04/07/2023
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
03/24/2023
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
03/23/2023
IUAA
USE AMENDMENT ACCEPTED
03/23/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
03/15/2023
IUAF
USE AMENDMENT FILED
03/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/14/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
03/14/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/14/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/14/2022
GNFR
FINAL REFUSAL E-MAILED
12/14/2022
CNFR
FINAL REFUSAL WRITTEN
12/14/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/25/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/07/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/07/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
10/20/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
10/19/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/09/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/09/2020
GNSL
LETTER OF SUSPENSION E-MAILED
09/09/2020
CNSL
SUSPENSION LETTER WRITTEN
09/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/10/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/19/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/19/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/19/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/19/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/19/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/10/2020
GNRT
NON-FINAL ACTION E-MAILED
02/10/2020
CNRT
NON-FINAL ACTION WRITTEN
02/10/2020
DOCK
ASSIGNED TO EXAMINER
01/29/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/30/2019
NWAP
NEW APPLICATION ENTERED
10/28/2019
Continuous trademark protection
Get notified about every new filing that threatens CAMBRIDGE PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.